| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.4 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |